Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Arie Belldegrun Insider Profile
11 Followers
Arie Belldegrun, COB, Pres & CEO, Director, Ten Percent Owner at Kite Pharma Inc, holds 8.36M shares in Allogene Therapeutics (Ticker: ALLO), holds 408.69K shares in Urogen Pharma (Ticker: URGN), holds 589.66K shares in Ginkgo Bioworks Holdings (Ticker: DNA).
Arie Belldegrun Kite Pharma Inc (KITE)COB, Pres & CEO, Director, Ten Percent Owner
Kite Pharma Inc (KITE)
COB, Pres & CEO, Director, Ten Percent Owner
Ranked #73,235 out of 103,103 Corporate Insiders
Profitable Transactions
4 out of 13 Profitable Transactions
Average Return
-7.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Arie Belldegrun holds in companies
Most Profitable Insider Trade
Stock:
Kite Pharma Inc
(KITE)
(KITE)
Rating:Informative Buy
Date:May 09, 2017 - May 09, 2018
Return:+149.20%
The most profitable trade made by Arie Belldegrun
Arie Belldegrun's Trading History
Kite Pharma Inc
Oct 05, 2017
―
Uninformative Sell
$575.51M
$994.51M
Allogene Therapeutics
Mar 24, 2023
Director
Uninformative Buy
―
$42.21M
Urogen Pharma
Sep 16, 2022
Director
Informative Buy
$800.00K
$3.42M
Kronos Bio
Oct 16, 2020
Director
Uninformative Buy
―
$4.01M
Ginkgo Bioworks Holdings
Jun 13, 2022
Director
Uninformative Buy
―
$725.28K
Talon Therapeutics Inc
―
―
―
―
List of latest transactions for each holding click on a transaction to see Arie Belldegrun's performance on stock
You May Also Like
Arie Belldegrun insider profile FAQ
What is the percentage of profitable transactions made by Arie Belldegrun?
The percentage of profitable transactions made by Arie Belldegrun is 31%.
What is the average return per transaction made by Arie Belldegrun?
The average return per transaction made by Arie Belldegrun is -7.20%.
What stocks does Arie Belldegrun hold?
Arie Belldegrun holds: KITE, ALLO, URGN, KRON, DNA, TLON stocks.
What was Arie Belldegrun’s latest transaction?
Arie Belldegrun latest transaction was an Uninformative Buy of ―.
What was Arie Belldegrun's most profitable transaction?
Arie Belldegrun’s most profitable transaction was an Informative Buy of KITE stock on May 9, 2017. The return on the trade was 149.20%.
What is Arie Belldegrun's role in Kite Pharma Inc?
Arie Belldegrun's role in Kite Pharma Inc is COB, Pres & CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.